Crossmark

Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2022.10.019

Published Print: 2023-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Díaz, Lidia Serrano

Navalón, Carles Iniesta

Espín, Rosa Gómez

Prado, Isabel Nicolás de

Redondo, Lorena Rentero
License Information

Text and Data Mining valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01
More Information

This article is maintained by: Elsevier

Article Title: Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2022.10.019

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.